Chemokine receptors and melanoma metastasis

Takashi Murakami, Adela R. Cardones, Samuel T Hwang

Research output: Contribution to journalReview article

131 Citations (Scopus)

Abstract

Cancer metastasis is the end result of a complex series of biologic events that leads to the formation of clinically significant secondary tumors at distant sites. The sites of distant metastasis are not random since certain tumors show a tendency to develop metastases in specific organs. Human melanoma, for example, demonstrates frequent metastasis to brain, lungs, lymph nodes, and skin. Herein, we review the evidence that suggests that a limited number of chemokine receptors may play critical roles in determining organ-selective metastasis in melanoma by regulating diverse processes such as chemoattraction, adhesion, and survival. In particular, we describe roles for CC chemokine receptor 7 (CCR7) in lymph node metastasis, CXC chemokine receptor 4 (CXCR4) in pulmonary metastasis, and CCR10 in skin metastasis, using a mouse model of melanoma. Preliminary evidence in this preclinical model suggests that inhibiting the function of these receptors may decrease the ability of cancer cells to disseminate to other sites and/or block their ability to survive and form tumors. Therefore, manipulation of the chemokine network could have therapeutic potential in human malignancies.

Original languageEnglish (US)
Pages (from-to)71-78
Number of pages8
JournalJournal of Dermatological Science
Volume36
Issue number2
DOIs
StatePublished - Nov 2004
Externally publishedYes

Fingerprint

Chemokine Receptors
Tumors
Melanoma
Neoplasm Metastasis
CCR7 Receptors
Skin
CXCR4 Receptors
Chemokines
Neoplasms
Brain
Adhesion
Cells
Lymph Nodes
Lung
Survival

ASJC Scopus subject areas

  • Dermatology

Cite this

Chemokine receptors and melanoma metastasis. / Murakami, Takashi; Cardones, Adela R.; Hwang, Samuel T.

In: Journal of Dermatological Science, Vol. 36, No. 2, 11.2004, p. 71-78.

Research output: Contribution to journalReview article

Murakami, Takashi ; Cardones, Adela R. ; Hwang, Samuel T. / Chemokine receptors and melanoma metastasis. In: Journal of Dermatological Science. 2004 ; Vol. 36, No. 2. pp. 71-78.
@article{548161cfdfe34ab094c79881b5d6e756,
title = "Chemokine receptors and melanoma metastasis",
abstract = "Cancer metastasis is the end result of a complex series of biologic events that leads to the formation of clinically significant secondary tumors at distant sites. The sites of distant metastasis are not random since certain tumors show a tendency to develop metastases in specific organs. Human melanoma, for example, demonstrates frequent metastasis to brain, lungs, lymph nodes, and skin. Herein, we review the evidence that suggests that a limited number of chemokine receptors may play critical roles in determining organ-selective metastasis in melanoma by regulating diverse processes such as chemoattraction, adhesion, and survival. In particular, we describe roles for CC chemokine receptor 7 (CCR7) in lymph node metastasis, CXC chemokine receptor 4 (CXCR4) in pulmonary metastasis, and CCR10 in skin metastasis, using a mouse model of melanoma. Preliminary evidence in this preclinical model suggests that inhibiting the function of these receptors may decrease the ability of cancer cells to disseminate to other sites and/or block their ability to survive and form tumors. Therefore, manipulation of the chemokine network could have therapeutic potential in human malignancies.",
author = "Takashi Murakami and Cardones, {Adela R.} and Hwang, {Samuel T}",
year = "2004",
month = "11",
doi = "10.1016/j.jdermsci.2004.03.002",
language = "English (US)",
volume = "36",
pages = "71--78",
journal = "Journal of Dermatological Science",
issn = "0923-1811",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Chemokine receptors and melanoma metastasis

AU - Murakami, Takashi

AU - Cardones, Adela R.

AU - Hwang, Samuel T

PY - 2004/11

Y1 - 2004/11

N2 - Cancer metastasis is the end result of a complex series of biologic events that leads to the formation of clinically significant secondary tumors at distant sites. The sites of distant metastasis are not random since certain tumors show a tendency to develop metastases in specific organs. Human melanoma, for example, demonstrates frequent metastasis to brain, lungs, lymph nodes, and skin. Herein, we review the evidence that suggests that a limited number of chemokine receptors may play critical roles in determining organ-selective metastasis in melanoma by regulating diverse processes such as chemoattraction, adhesion, and survival. In particular, we describe roles for CC chemokine receptor 7 (CCR7) in lymph node metastasis, CXC chemokine receptor 4 (CXCR4) in pulmonary metastasis, and CCR10 in skin metastasis, using a mouse model of melanoma. Preliminary evidence in this preclinical model suggests that inhibiting the function of these receptors may decrease the ability of cancer cells to disseminate to other sites and/or block their ability to survive and form tumors. Therefore, manipulation of the chemokine network could have therapeutic potential in human malignancies.

AB - Cancer metastasis is the end result of a complex series of biologic events that leads to the formation of clinically significant secondary tumors at distant sites. The sites of distant metastasis are not random since certain tumors show a tendency to develop metastases in specific organs. Human melanoma, for example, demonstrates frequent metastasis to brain, lungs, lymph nodes, and skin. Herein, we review the evidence that suggests that a limited number of chemokine receptors may play critical roles in determining organ-selective metastasis in melanoma by regulating diverse processes such as chemoattraction, adhesion, and survival. In particular, we describe roles for CC chemokine receptor 7 (CCR7) in lymph node metastasis, CXC chemokine receptor 4 (CXCR4) in pulmonary metastasis, and CCR10 in skin metastasis, using a mouse model of melanoma. Preliminary evidence in this preclinical model suggests that inhibiting the function of these receptors may decrease the ability of cancer cells to disseminate to other sites and/or block their ability to survive and form tumors. Therefore, manipulation of the chemokine network could have therapeutic potential in human malignancies.

UR - http://www.scopus.com/inward/record.url?scp=7044245791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7044245791&partnerID=8YFLogxK

U2 - 10.1016/j.jdermsci.2004.03.002

DO - 10.1016/j.jdermsci.2004.03.002

M3 - Review article

C2 - 15519136

AN - SCOPUS:7044245791

VL - 36

SP - 71

EP - 78

JO - Journal of Dermatological Science

JF - Journal of Dermatological Science

SN - 0923-1811

IS - 2

ER -